Discordance Between Neutrophil to Lymphocyte Ratio and High Sensitivity C-Reactive Protein to Predict Clinical Events in Patients with Stable Coronary Artery Disease: A Large-Scale Cohort Study

References

• Lawler PR, Bhatt DL, Godoy LC, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113–131. doi:10.1093/eurheartj/ehaa099
   PubMed Web of Science ®Google Scholar
• Bohula EA, Giugliano RP, Leiter LA, et al. Inflammatory and Cholesterol Risk in the Fourier Trial. Circulation. 2018;138(2):131–140. doi:10.1161/CIRCULATIONAHA.118.034032
   PubMed Web of Science ®Google Scholar
• Ridker PM, MacFadyen JG, Everett BM, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319–328. doi:10.1016/S0140-6736(17)32814-3
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132–140.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar
• Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838–1847. doi:10.1056/NEJMoa2021372
   PubMed Web of Science ®Google Scholar
• Tardif J-C, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–2505. doi:10.1056/NEJMoa1912388
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aurora RG, Siswanto BB, et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 2022;33(2):137–143. doi:10.1097/MCA.0000000000001040
   PubMed Web of Science ®Google Scholar
• Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896–903. doi:10.1093/eurheartj/ehaa1034
   PubMed Web of Science ®Google Scholar
• He J, Bian X, Song C, et al. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol. 2022;21(1):156. doi:10.1186/s12933-022-01583-9
   PubMed Web of Science ®Google Scholar
• Sager HB, Koenig W. Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio. Eur Heart J. 2021;42(9):904–906. doi:10.1093/eurheartj/ehaa1104
   PubMed Web of Science ®Google Scholar
• Wada H, Dohi T, Miyauchi K, et al. Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level. Int Heart J. 2020;61(3):447–453. doi:10.1536/ihj.19-543
   PubMed Web of Science ®Google Scholar
• Association AD. 2. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
   PubMedGoogle Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285–e350. doi:10.1016/j.jacc.2018.11.003
   PubMed Web of Science ®Google Scholar
• Rosinger A, Carroll MD, Lacher D, et al. Trends in total cholesterol, triglycerides, and low-density lipoprotein in US adults, 1999–2014. JAMA Cardiol. 2017;2(3):339–341. doi:10.1001/jamacardio.2016.4396
   PubMed Web of Science ®Google Scholar
• He J, Yang M, Song C, et al. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes. J Endocrinol Invest. 2023. doi:10.1007/s40618-023-02203-3
   Web of Science ®Google Scholar
• Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–1722. doi:10.1056/NEJMoa1615664
   PubMed Web of Science ®Google Scholar
• Held C, White HD, Stewart RAH, et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(10). doi:10.1161/JAHA.116.005077.
   Web of Science ®Google Scholar
• Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352(1):29–38. doi:10.1056/NEJMoa042000
   PubMed Web of Science ®Google Scholar
• Xu N, Tang X-F, Yao Y, et al. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction. Catheter Cardiovasc Interv. 2018;91(S1):551–557. doi:10.1002/ccd.27495
   PubMedGoogle Scholar
• Papa A, Emdin M, Passino C, et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395(1–2):27–31. doi:10.1016/j.cca.2008.04.019
   PubMed Web of Science ®Google Scholar
• Wada H, Dohi T, Miyauchi K, et al. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease. Atherosclerosis. 2017;265:35–40. doi:10.1016/j.atherosclerosis.2017.08.007
   PubMed Web of Science ®Google Scholar
• Bressi E, Mangiacapra F, Ricottini E, et al. Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. J Cardiovasc Transl Res. 2018;11(6):517–523. doi:10.1007/s12265-018-9829-6
   PubMed Web of Science ®Google Scholar
• Silvestre-Roig C, Braster Q, Ortega-Gomez A, et al. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327–340. doi:10.1038/s41569-019-0326-7
   PubMed Web of Science ®Google Scholar
• Burn GL, Foti A, Marsman G, et al. The Neutrophil. Immunity. 2021;54(7):1377–1391. doi:10.1016/j.immuni.2021.06.006
   PubMed Web of Science ®Google Scholar
• Warnatsch A, Ioannou M, Wang Q, et al. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349(6245):316–320. doi:10.1126/science.aaa8064
   PubMed Web of Science ®Google Scholar
• Gordon AS. Some aspects of hormonal influences upon the leukocytes. Ann N Y Acad Sci. 1955;59(5):907–927. doi:10.1111/j.1749-6632.1955.tb45990.x
   PubMed Web of Science ®Google Scholar
• Ulich TR, Keys M, Ni RX, et al. The contributions of adrenal hormones, hemodynamic factors, and the endotoxin-related stress reaction to stable prostaglandin analog-induced peripheral lymphopenia and neutrophilia. J Leukoc Biol. 1988;43(1):5–10. doi:10.1002/jlb.43.1.5
   PubMed Web of Science ®Google Scholar
• Hofmann U, Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res. 2015;116(2):354–367. doi:10.1161/CIRCRESAHA.116.304072
   PubMed Web of Science ®Google Scholar
• Zafrir B, Hussein S, Jaffe R, et al. Lymphopenia and mortality among patients undergoing coronary angiography: long-term follow-up study. Cardiol J. 2022;29(4):637–646. doi:10.5603/CJ.a2020.0141
   PubMed Web of Science ®Google Scholar
• Le Campion A, Gagnerault M-C, Auffray C, et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood. 2009;114(9):1784–1793. doi:10.1182/blood-2008-12-192120
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–935. doi:10.1161/CIRCULATIONAHA.106.672402
   PubMed Web of Science ®Google Scholar
• Su X, Cai X, Pan Y, et al. Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis. Eur J Prev Cardiol. 2022;29(18):2349–2358. doi:10.1093/eurjpc/zwac223
   PubMed Web of Science ®Google Scholar
• Hu C, Zhang J, Liu J, et al. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol. 2020;19(1):116. doi:10.1186/s12933-020-01091-8
   PubMed Web of Science ®Google Scholar
• Knuuti J, Wijns W, Saraste A, et al. ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477. doi:10.1093/eurheartj/ehz425
   PubMed Web of Science ®Google Scholar
• Collaboration AT. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. doi:10.1136/bmj.324.7329.71
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860.
   PubMed Web of Science ®Google Scholar
• He J, Yuan S, Song C, et al. High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study. Cardiovasc Diabetol. 2023;22(1):289. doi:10.1186/s12933-023-02016-x
   PubMed Web of Science ®Google Scholar
• He J, Song C, Wang H, et al. Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: a large-scale cohort study. Diabetes Res Clin Pract;2023:110693. doi:10.1016/j.diabres.2023.110693
   PubMed Web of Science ®Google Scholar